Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InspireMD Inc NSPR

Healthcare Medical Instruments & Supplies
InspireMD, Inc. is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet... see more

Recent & Breaking News (NDAQ:NSPR)

InspireMD Reports Updated Positive CGuard(TM) EPS Data Presented at VEITH 2019

GlobeNewswire November 26, 2019

UPDATE: InspireMD Announces Third Quarter 2019 Financial Results

GlobeNewswire November 12, 2019

InspireMD Announces Third Quarter 2019 Financial Results

GlobeNewswire November 12, 2019

InspireMD to Report Third Quarter 2019 Financial Results and Provide Business Update on Tuesday, November 12

GlobeNewswire November 5, 2019

InspireMD, Inc. Announces Pricing of $5 Million Underwritten Public Offering

GlobeNewswire September 19, 2019

InspireMD Provides Business Update

GlobeNewswire September 9, 2019

InspireMD to Present at the HC Wainwright 21st Annual Global Investment Conference

GlobeNewswire September 9, 2019

InspireMD Announces Notification of NYSE AMERICAN Listing Deficiency

GlobeNewswire August 9, 2019

InspireMD Announces Second Quarter 2019 Financial Results

GlobeNewswire August 6, 2019

InspireMD to Report Second Quarter 2019 Financial Results and Provide Business Update on Tuesday, August 6

GlobeNewswire July 30, 2019

InspireMD Announces First Quarter 2019 Financial Results

GlobeNewswire May 14, 2019

InspireMD to Report First Quarter 2019 Financial Results and Provide Business Update on Tuesday, May 14

GlobeNewswire May 7, 2019

Thinking about buying stock in Cronos Group Inc., Facebook Inc., InspireMD Inc., Pulmatrix Inc., or Sangamo Therapeutics?

PR Newswire April 2, 2019

InspireMD Announces Results from Initial Clinical Study of The CGuard™ Embolic Prevention System (EPS) with SmartFit™ Technology

GlobeNewswire January 22, 2019

InspireMD’s CGuard™ Embolic Prevention System to be Prominently Featured in Live Case Transmissions at LINC, 22nd to the 25th January 2019, in Leipzig, Germany

GlobeNewswire January 18, 2019

InspireMD Announces the Distribution of CGuard™ Embolic Prevention System in South Africa

GlobeNewswire January 14, 2019

InspireMD Receives Noncompliance Notice from NYSE American

GlobeNewswire January 11, 2019

InspireMD Announces Publication of Meta-Analysis Citing Benefits of Next Generation Mesh-Covered Carotid Stent Systems

GlobeNewswire December 18, 2018

InspireMD Announces Positive Long-Term Safety and Efficacy Data from Ongoing CGuard™ EPS Registries at the Recent 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium)

GlobeNewswire November 29, 2018

InspireMD Announces Regulatory and Reimbursement Approval of CGuard™ Embolic Prevention System in Australia

GlobeNewswire November 28, 2018